OPUS GENETICS INC.
Advancing first-in-class gene therapies for inherited retinal diseases
Raleigh, United States · Founded 2024
- Headquarters
- Raleigh, North Carolina
- Employees
- 1–10
- Founded
- 2024
- Business Model
- B2B
- Website
- opusgtx.com
About
Opus Genetics is a clinical-stage ophthalmic biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs). The company's pipeline comprises seven AAV-based gene therapy assets and a small-molecule therapy targeting conditions including Leber congenital amaurosis (LCA), bestrophinopathy, and retinitis pigmentosa, with one FDA-approved product and multiple late-stage clinical programs.
Summary
OPUS GENETICS INC. is a Biotech company based in Raleigh, United States, founded in 2024.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/opus-genetics-inc"><img src="https://indexed.vc/api/badge/company/opus-genetics-inc" alt="OPUS GENETICS INC. on Indexed.vc" width="260" height="76" /></a>